Europeiska unionen - svenska - EMA (European Medicines Agency)

teva pharma gmbh - laquinimod - multipel skleros - behandling av multipel skleros.

Europeiska unionen - svenska - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - läkemedel som används vid diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trippel kombinationsterapi) som ett komplement till kost och motion hos patienter bristfälligt kontrollerad på deras maximal tolererad dos av metformin och en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

krka d.d., novo mesto - sitagliptin - filmdragerad tablett - 100 mg - sitagliptin 100 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

krka d.d., novo mesto - sitagliptin - filmdragerad tablett - 25 mg - sitagliptin 25 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

krka d.d., novo mesto - sitagliptin - filmdragerad tablett - 50 mg - sitagliptin 50 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orion corporation - sitagliptinhydrokloridmonohydrat - filmdragerad tablett - 25 mg - sitagliptinhydrokloridmonohydrat 28,34 mg aktiv substans